Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

ClinicalTrials.gov ID: NCT07784270

Public ClinicalTrials.gov record NCT07784270. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Aug 26, 2026, 1:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Double-Blind, Placebo-Controlled Multicentre Trial to Evaluate the Efficacy and Safety of AZD6234 in Participants With Type 2 Diabetes Mellitus and Obesity or Overweight (SELENE 2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in percent body weight change from baseline at 68 weeks of treatment

Study identification

NCT ID
NCT07784270
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,500 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 20, 2026
Primary completion
Aug 8, 2028
Completion
Aug 8, 2028
Last update posted
Aug 24, 2026

2026 – 2028

United States locations

U.S. sites
50
U.S. states
22
U.S. cities
47
Facility City State ZIP Site status
Research Site Fairhope Alabama 36532
Research Site Huntsville Alabama 35801
Research Site Mesa Arizona 85213
Research Site Phoenix Arizona 85044
Research Site Tucson Arizona 85715
Research Site Little Rock Arkansas 72205
Research Site Bakersfield California 93309
Research Site Gardena California 90247
Research Site Lincoln California 95648
Research Site Torrance California 90503
Research Site Walnut Creek California 94598
Research Site Coral Gables Florida 33134
Research Site Fleming Island Florida 32003
Research Site Fort Lauderdale Florida 33316
Research Site Ocoee Florida 34761
Research Site Woodstock Georgia 30189
Research Site Chicago Illinois 60640
Research Site Melrose Park Illinois 60160
Research Site Lenexa Kansas 66219
Research Site Newton Kansas 67114
Research Site Monroe Louisiana 71201
Research Site Beltsville Maryland 20705
Research Site Lanham Maryland 20706
Research Site Oxon Hill Maryland 20745
Research Site North Dartmouth Massachusetts 02747
Research Site Farmington Hills Michigan 48336
Research Site Fayette Mississippi 39069
Research Site Kansas City Missouri 64111
Research Site St Louis Missouri 63141
Research Site Omaha Nebraska 68114
Research Site Omaha Nebraska 68144
Research Site Eatontown New Jersey 07724
Research Site Somerset New Jersey 08873
Research Site Warren Township New Jersey 07059
Research Site Greensboro North Carolina 27408
Research Site Monroe North Carolina 28112
Research Site Munroe Falls Ohio 44262
Research Site Scottdale Pennsylvania 15683
Research Site Franklin Tennessee 37067
Research Site Knoxville Tennessee 37938
Research Site DeSoto Texas 75115
Research Site El Paso Texas 79935
Research Site Houston Texas 77099
Research Site Midland Texas 79707
Research Site Pasadena Texas 77504
Research Site San Antonio Texas 78207
Research Site San Antonio Texas 78215
Research Site San Antonio Texas 78251
Research Site Manassas Virginia 20110
Research Site Norfolk Virginia 23504

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 168 non-U.S. sites.

Recently updated Diabetes Mellitus, Type 2 trials

Other public records listing Diabetes Mellitus, Type 2. Sorted by last update posted; newest first. Not a recommendation.

All Diabetes Mellitus, Type 2 trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07784270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2026 · Synced Aug 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07784270 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →